HEADER TRANSFERASE 14-MAR-11 2YCF TITLE CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR TITLE 2 PV1531 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 210-530; COMPND 5 SYNONYM: CHECKPOINT KINASE 2, CDS1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDZ1927 KEYWDS TRANSFERASE, ANTICANCER, ANTICANCER DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR G.T.LOUNTOS,A.G.JOBSON,J.E.TROPEA,C.R.SELF,Y.POMMIER,R.H.SHOEMAKER, AUTHOR 2 G.ZHANG,D.S.WAUGH REVDAT 2 20-DEC-23 2YCF 1 REMARK LINK REVDAT 1 16-NOV-11 2YCF 0 JRNL AUTH G.T.LOUNTOS,A.G.JOBSON,J.E.TROPEA,C.R.SELF,G.ZHANG, JRNL AUTH 2 Y.POMMIER,R.H.SHOEMAKER,D.S.WAUGH JRNL TITL STRUCTURAL CHARACTERIZATION OF INHIBITOR COMPLEXES WITH JRNL TITL 2 CHECKPOINT KINASE 2 (CHK2), A DRUG TARGET FOR CANCER JRNL TITL 3 THERAPY. JRNL REF J.STRUCT.BIOL. V. 176 292 2011 JRNL REFN ISSN 1047-8477 JRNL PMID 21963792 JRNL DOI 10.1016/J.JSB.2011.09.008 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0104 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 41231 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2183 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.77 REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 REFLECTION IN BIN (WORKING SET) : 3011 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE SET COUNT : 163 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2286 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 259 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.14000 REMARK 3 B22 (A**2) : -0.14000 REMARK 3 B33 (A**2) : 0.20000 REMARK 3 B12 (A**2) : -0.07000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.104 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.099 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.067 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.511 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2442 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3315 ; 1.217 ; 2.005 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 308 ; 4.974 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 99 ;37.189 ;24.848 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 473 ;13.455 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;20.431 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 383 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1789 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1466 ; 0.750 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2397 ; 1.410 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 976 ; 2.058 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 905 ; 3.518 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 210 A 300 REMARK 3 ORIGIN FOR THE GROUP (A): 53.7637 11.7047 -3.7768 REMARK 3 T TENSOR REMARK 3 T11: 0.0409 T22: 0.0792 REMARK 3 T33: 0.0369 T12: -0.0146 REMARK 3 T13: 0.0097 T23: 0.0075 REMARK 3 L TENSOR REMARK 3 L11: 2.0520 L22: 0.5481 REMARK 3 L33: -0.0328 L12: 0.9192 REMARK 3 L13: -0.1714 L23: -0.0382 REMARK 3 S TENSOR REMARK 3 S11: 0.0543 S12: -0.1352 S13: 0.0124 REMARK 3 S21: -0.0347 S22: -0.0589 S23: -0.0161 REMARK 3 S31: -0.0308 S32: -0.0058 S33: 0.0047 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 301 A 374 REMARK 3 ORIGIN FOR THE GROUP (A): 37.9183 8.6887 -9.9219 REMARK 3 T TENSOR REMARK 3 T11: 0.0420 T22: 0.0746 REMARK 3 T33: 0.0352 T12: 0.0115 REMARK 3 T13: -0.0072 T23: 0.0419 REMARK 3 L TENSOR REMARK 3 L11: 1.4284 L22: 0.4904 REMARK 3 L33: 0.6139 L12: 0.3892 REMARK 3 L13: -0.4308 L23: -0.1264 REMARK 3 S TENSOR REMARK 3 S11: 0.0056 S12: 0.1571 S13: 0.1421 REMARK 3 S21: -0.0196 S22: 0.0193 S23: 0.0307 REMARK 3 S31: 0.0153 S32: 0.0426 S33: -0.0249 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 375 A 448 REMARK 3 ORIGIN FOR THE GROUP (A): 25.7145 4.3261 6.2431 REMARK 3 T TENSOR REMARK 3 T11: 0.0398 T22: 0.0427 REMARK 3 T33: 0.0889 T12: 0.0115 REMARK 3 T13: -0.0166 T23: -0.0171 REMARK 3 L TENSOR REMARK 3 L11: 0.4419 L22: 0.3103 REMARK 3 L33: 0.6768 L12: 0.1197 REMARK 3 L13: 0.0165 L23: -0.5217 REMARK 3 S TENSOR REMARK 3 S11: 0.0112 S12: 0.0326 S13: 0.0800 REMARK 3 S21: -0.0198 S22: -0.0377 S23: 0.0554 REMARK 3 S31: 0.0818 S32: -0.0361 S33: 0.0265 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 449 A 510 REMARK 3 ORIGIN FOR THE GROUP (A): 29.8418 1.0919 -14.7186 REMARK 3 T TENSOR REMARK 3 T11: 0.0658 T22: 0.1438 REMARK 3 T33: 0.0006 T12: -0.0075 REMARK 3 T13: -0.0499 T23: -0.0265 REMARK 3 L TENSOR REMARK 3 L11: 1.0766 L22: 1.2772 REMARK 3 L33: 0.3144 L12: 0.6798 REMARK 3 L13: -0.2521 L23: -0.0470 REMARK 3 S TENSOR REMARK 3 S11: -0.1554 S12: 0.3070 S13: -0.0875 REMARK 3 S21: -0.1605 S22: 0.0436 S23: 0.2274 REMARK 3 S31: 0.2175 S32: -0.1664 S33: 0.1119 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2YCF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1290047689. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44051 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 48.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.66000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2CN5 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7.8, 0.1 M MAGNESIUM REMARK 280 NITRATE, 14% W/V PEG 3350, 16% V/V ETHYLENE GLYCOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.42600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 31.21300 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 31.21300 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 62.42600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 31.21300 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 209 REMARK 465 ARG A 254 REMARK 465 LYS A 255 REMARK 465 PHE A 256 REMARK 465 ALA A 257 REMARK 465 ILE A 258 REMARK 465 GLY A 259 REMARK 465 SER A 260 REMARK 465 ALA A 261 REMARK 465 ARG A 262 REMARK 465 GLU A 263 REMARK 465 ALA A 264 REMARK 465 ASP A 265 REMARK 465 PRO A 266 REMARK 465 ALA A 267 REMARK 465 LEU A 268 REMARK 465 VAL A 511 REMARK 465 LEU A 512 REMARK 465 ALA A 513 REMARK 465 GLN A 514 REMARK 465 PRO A 515 REMARK 465 SER A 516 REMARK 465 THR A 517 REMARK 465 SER A 518 REMARK 465 ARG A 519 REMARK 465 LYS A 520 REMARK 465 ARG A 521 REMARK 465 PRO A 522 REMARK 465 ARG A 523 REMARK 465 GLU A 524 REMARK 465 GLY A 525 REMARK 465 GLU A 526 REMARK 465 ALA A 527 REMARK 465 GLU A 528 REMARK 465 GLY A 529 REMARK 465 ALA A 530 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 223 -144.28 -122.48 REMARK 500 ALA A 294 -138.59 -128.73 REMARK 500 ARG A 346 -0.90 75.15 REMARK 500 ASP A 347 41.35 -141.93 REMARK 500 ASP A 368 89.26 68.92 REMARK 500 LEU A 467 46.08 -93.21 REMARK 500 THR A 506 153.31 71.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 601 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 347 OD2 REMARK 620 2 ASP A 368 OD2 93.5 REMARK 620 3 HOH A2107 O 91.2 175.0 REMARK 620 4 HOH A2132 O 162.2 86.2 89.8 REMARK 620 5 HOH A2133 O 91.9 85.5 92.9 105.9 REMARK 620 6 HOH A2138 O 86.1 91.5 90.4 76.1 176.2 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YCF A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NO3 A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WTI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XBJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2CN8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH REMARK 900 DEBROMOHYMENIALDISINE REMARK 900 RELATED ID: 2W0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2WTC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2WTJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XM9 RELATED DB: PDB REMARK 900 STRUCTURE OF A SMALL MOLECULE INHIBITOR WITH THE KINASE DOMAIN OF REMARK 900 CHK2 REMARK 900 RELATED ID: 2W7X RELATED DB: PDB REMARK 900 CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF REMARK 900 CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019 REMARK 900 RELATED ID: 1GXC RELATED DB: PDB REMARK 900 FHA DOMAIN FROM HUMAN CHK2 KINASE IN COMPLEX WITH A SYNTHETIC REMARK 900 PHOSPHOPEPTIDE REMARK 900 RELATED ID: 2CN5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP REMARK 900 RELATED ID: 2XM8 RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF A SMALL MOLECULE INHIBITOR BOUND TO THE REMARK 900 KINASE DOMAIN OF CHK2 REMARK 900 RELATED ID: 2WTD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR DBREF 2YCF A 210 530 UNP O96017 CHK2_HUMAN 210 530 SEQADV 2YCF MET A 209 UNP O96017 EXPRESSION TAG SEQRES 1 A 322 MET SER VAL TYR PRO LYS ALA LEU ARG ASP GLU TYR ILE SEQRES 2 A 322 MET SER LYS THR LEU GLY SER GLY ALA CYS GLY GLU VAL SEQRES 3 A 322 LYS LEU ALA PHE GLU ARG LYS THR CYS LYS LYS VAL ALA SEQRES 4 A 322 ILE LYS ILE ILE SER LYS ARG LYS PHE ALA ILE GLY SER SEQRES 5 A 322 ALA ARG GLU ALA ASP PRO ALA LEU ASN VAL GLU THR GLU SEQRES 6 A 322 ILE GLU ILE LEU LYS LYS LEU ASN HIS PRO CYS ILE ILE SEQRES 7 A 322 LYS ILE LYS ASN PHE PHE ASP ALA GLU ASP TYR TYR ILE SEQRES 8 A 322 VAL LEU GLU LEU MET GLU GLY GLY GLU LEU PHE ASP LYS SEQRES 9 A 322 VAL VAL GLY ASN LYS ARG LEU LYS GLU ALA THR CYS LYS SEQRES 10 A 322 LEU TYR PHE TYR GLN MET LEU LEU ALA VAL GLN TYR LEU SEQRES 11 A 322 HIS GLU ASN GLY ILE ILE HIS ARG ASP LEU LYS PRO GLU SEQRES 12 A 322 ASN VAL LEU LEU SER SER GLN GLU GLU ASP CYS LEU ILE SEQRES 13 A 322 LYS ILE THR ASP PHE GLY HIS SER LYS ILE LEU GLY GLU SEQRES 14 A 322 THR SER LEU MET ARG THR LEU CYS GLY THR PRO THR TYR SEQRES 15 A 322 LEU ALA PRO GLU VAL LEU VAL SER VAL GLY THR ALA GLY SEQRES 16 A 322 TYR ASN ARG ALA VAL ASP CYS TRP SER LEU GLY VAL ILE SEQRES 17 A 322 LEU PHE ILE CYS LEU SER GLY TYR PRO PRO PHE SER GLU SEQRES 18 A 322 HIS ARG THR GLN VAL SER LEU LYS ASP GLN ILE THR SER SEQRES 19 A 322 GLY LYS TYR ASN PHE ILE PRO GLU VAL TRP ALA GLU VAL SEQRES 20 A 322 SER GLU LYS ALA LEU ASP LEU VAL LYS LYS LEU LEU VAL SEQRES 21 A 322 VAL ASP PRO LYS ALA ARG PHE THR THR GLU GLU ALA LEU SEQRES 22 A 322 ARG HIS PRO TRP LEU GLN ASP GLU ASP MET LYS ARG LYS SEQRES 23 A 322 PHE GLN ASP LEU LEU SER GLU GLU ASN GLU SER THR ALA SEQRES 24 A 322 LEU PRO GLN VAL LEU ALA GLN PRO SER THR SER ARG LYS SEQRES 25 A 322 ARG PRO ARG GLU GLY GLU ALA GLU GLY ALA HET YCF A 600 32 HET MG A 601 1 HET NO3 A 602 4 HETNAM YCF (2E)-N-HYDROXY-2-[1-(4-{[(4-{(1E)-1-[2-(N'- HETNAM 2 YCF HYDROXYCARBAMIMIDOYL)HYDRAZINYLIDENE]ETHYL}PHENYL) HETNAM 3 YCF CARBAMOYL]AMINO}PHENYL) HETNAM 4 YCF ETHYLIDENE]HYDRAZINECARBOXIMIDAMIDE HETNAM MG MAGNESIUM ION HETNAM NO3 NITRATE ION FORMUL 2 YCF C19 H24 N10 O3 FORMUL 3 MG MG 2+ FORMUL 4 NO3 N O3 1- FORMUL 5 HOH *259(H2 O) HELIX 1 1 PRO A 213 GLU A 219 1 7 HELIX 2 2 ASN A 269 LEU A 280 1 12 HELIX 3 3 LEU A 309 VAL A 314 1 6 HELIX 4 4 LYS A 320 ASN A 341 1 22 HELIX 5 5 LYS A 349 GLU A 351 5 3 HELIX 6 6 THR A 378 GLY A 386 1 9 HELIX 7 7 ALA A 392 VAL A 399 1 8 HELIX 8 8 ARG A 406 GLY A 423 1 18 HELIX 9 9 SER A 435 GLY A 443 1 9 HELIX 10 10 ILE A 448 ALA A 453 1 6 HELIX 11 11 SER A 456 LEU A 467 1 12 HELIX 12 12 THR A 476 ARG A 482 1 7 HELIX 13 13 HIS A 483 GLN A 487 5 5 HELIX 14 14 ASP A 488 ASN A 503 1 16 SHEET 1 AA 5 TYR A 220 SER A 228 0 SHEET 2 AA 5 GLY A 232 GLU A 239 -1 O VAL A 234 N LEU A 226 SHEET 3 AA 5 LYS A 244 ILE A 251 -1 O LYS A 244 N GLU A 239 SHEET 4 AA 5 TYR A 297 GLU A 302 -1 O TYR A 297 N ILE A 251 SHEET 5 AA 5 ILE A 288 ASP A 293 -1 N LYS A 289 O VAL A 300 SHEET 1 AB 3 GLY A 307 GLU A 308 0 SHEET 2 AB 3 VAL A 353 LEU A 355 -1 N LEU A 355 O GLY A 307 SHEET 3 AB 3 ILE A 364 ILE A 366 -1 O LYS A 365 N LEU A 354 SHEET 1 AC 2 ILE A 343 ILE A 344 0 SHEET 2 AC 2 LYS A 373 ILE A 374 -1 O LYS A 373 N ILE A 344 LINK OD2 ASP A 347 MG MG A 601 1555 1555 2.05 LINK OD2 ASP A 368 MG MG A 601 1555 1555 2.09 LINK MG MG A 601 O HOH A2107 1555 1555 2.15 LINK MG MG A 601 O HOH A2132 1555 1555 2.15 LINK MG MG A 601 O HOH A2133 1555 1555 1.97 LINK MG MG A 601 O HOH A2138 1555 1555 2.24 SITE 1 AC1 18 LYS A 224 LEU A 226 CYS A 231 ILE A 251 SITE 2 AC1 18 GLU A 273 LEU A 301 MET A 304 GLU A 305 SITE 3 AC1 18 GLY A 307 LEU A 354 THR A 367 ASP A 368 SITE 4 AC1 18 GLY A 370 HOH A2059 HOH A2066 HOH A2112 SITE 5 AC1 18 HOH A2132 HOH A2256 SITE 1 AC2 6 ASP A 347 ASP A 368 HOH A2107 HOH A2132 SITE 2 AC2 6 HOH A2133 HOH A2138 SITE 1 AC3 7 LEU A 375 GLY A 403 TYR A 404 ASN A 405 SITE 2 AC3 7 ARG A 406 HOH A2258 HOH A2259 CRYST1 90.465 90.465 93.639 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011054 0.006382 0.000000 0.00000 SCALE2 0.000000 0.012764 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010679 0.00000